Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy. - Reustle, Anna; Di Marco, Moreno; Meyerhoff, Carolin; Nelde, Annika; Walz, Juliane S.; Winter, Stefan; Kandabarau, Siahei; Büttner, Florian; Haag, Mathias; Backert, Linus; Kowalewski, Daniel J.; Rausch, Steffen; et al. (Genome Medicine, 2020)